The possible efficacy of BTK inhibitors lessen... - CLL Support

CLL Support

23,257 members39,957 posts

The possible efficacy of BTK inhibitors lessening the effects of COVID-19

bkoffman profile image
bkoffmanCLL CURE Hero
17 Replies

Evaluating the effects and outcomes of COVID-19 infection in cancer patients:

In this week's CLL Society Tuesday Alert, Dr. Alan Skarbnik shared that while China, and Barcelona, Spain yield data, and our author himself, has looked into the possible efficacy of BTK inhibitors lessening the effects of COVID-19, the full picture which might adequately address cancer patients’ worries remains incomplete. Nevertheless, we urge you to read Dr. Skarbnik’s interesting article to keep in the know with what is being analyzed. Read here: bit.ly/2MB6jJ2

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
17 Replies
Mystic75 profile image
Mystic75

Thank you!

JigFettler profile image
JigFettlerVolunteer

2 months ago NSAIDs were recommended to be avoided with COVID - now in a therapeutic trial. Hydroxychloroquin to BTKIs, Ibuprofen to Remdesovir - is this not evidence for no one really knowing? Or perhaps reflects the extraordinary complexity of the the Covid illness.

Nevertheless - thank you for the opportunity of hope.

Best wishes

Jig

Ernest2 profile image
Ernest2

Many thanks for that Brian, seems to confirm the good news for CLLers particularly if we have some Ibrutinib in the back pocket

For cancer patients as a whole the 33% mortality rate compares against that for the general population of about 14% if I take the 70 to 79 year age group, using data from the following website:

statista.com/statistics/110...

So risk about doubled. There are probably some factors I've missed there.

I spoke to my consultant last week and my understanding was all CLLers who had contracted Covid-19 had done ok. (Low numbers though, like the Barcelona set).

I am hoping this Covid stuff is going to mysteriously disapear.

Best wishes to all,

Ernest

bkoffman profile image
bkoffmanCLL CURE Hero

ASH's very small registry has a MR of about 1 in 3 in CLL.

avzuclav profile image
avzuclav

Fresh data on the subject of BTK inhibition with COVID-19:

immunology.sciencemag.org/c...

Less data but more drama here:

forbes.com/sites/nathanvard...

zaax profile image
zaax

Does anyone know what is the number of people have to go to hospital compared the to normal population?

cajunjeff profile image
cajunjeff in reply tozaax

The hospitalization rate is calculated by dividing the number of people who are currently hospitalized by the number of active cases, which is the number of total cases minus deaths and estimated recoveries.

I read in Texas it was just under 10 % . But I think that is misleading because so many covid cases go unreported.

My guess is that the hospitalization rate is under 5 % for all cases and the mortality rate under 1%. My rationale is that if a state has 50000 confirmed covid cases, it may have several times that cases where people had mild symptoms or no symptoms and never got tested.

bkoffman profile image
bkoffmanCLL CURE Hero in reply tocajunjeff

I suspect the same.

zaax profile image
zaax in reply tocajunjeff

Sorry I meant us with CLL v the normal population

bkoffman profile image
bkoffmanCLL CURE Hero

Very small numbers on the ASH registry record that too. We can a link on our website, then just filter for CLL.

Jonquiljo profile image
Jonquiljo

Do you mean this link: ashresearchcollaborative.or... ?

bkoffman profile image
bkoffmanCLL CURE Hero in reply toJonquiljo

Yes, put CLL in as the filter. Looks like never having smoked helps.

Jonquiljo profile image
Jonquiljo in reply tobkoffman

Yup. Small data sets aren't very helpful!

Big_Dee profile image
Big_Dee

Hello bkoffman

One only needs to read latest headline, "Lancet, New England Journal retract Covid-19 studies, including one that raised safety concerns about malaria drugs" to see how the CV-19 has been politicized, sad. Thanks for your guiding light. Blessings.

bkoffman profile image
bkoffmanCLL CURE Hero in reply toBig_Dee

Makes me sad both as a patient and as a doctor/scientist.

Jonquiljo profile image
Jonquiljo in reply toBig_Dee

COVID-19 has been enormously politicized and subsequently turned into a chaotic scare-fest in the news media. We have all been living in that nightmare for a very long time. It’s hard to figure out what is real and what isn’t. After all this time, I feel not much more informed than I was in February. Since COVID is of special importance to anyone with CLL - we all want facts, not hype and political nonsense.

From what I gather about the recent retractions of articles in scientific journals is that the data sources were not very sound - a common problem when people use 3rd party data to make some point. A lot of over-eager people looking to get their papers into journals fast - and instead cut corners.

I can understand the need for data as COVID is such a large and overwhelming problem. This just makes me wonder how the “peer-review” system has broken down in the midst of the pandemic. Any first rate journal should review an article thoroughly so that later retraction is highly unlikely. This just makes scientific and medical journals look only a bit better than tabloids when it comes to COVID. When you add pre-publication sites to the mix, it really muddies the water.

bkoffman profile image
bkoffmanCLL CURE Hero

Lancet has a bad reputation for shoddy reviews but NEJM is the pinnacle medical journal.

Not what you're looking for?

You may also like...

The lowdown on Covid vaccine efficacy and blood cancer

Around 152,000 people in the UK have died with Covid19 on their death certificate. Around 230,000...

Response rate to vaccines against Covid-19 depending on the type of hematological disease and depending on the treatment .

COVID-19 Vaccine is Safe but 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies....
Yalokin profile image

Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience

This is the full report from ASH Publications Blood Journam yesterday by Dr Mayo et al....
Jm954 profile image
Administrator

The Benefits of Exercise with CLL and COVID-19

With CLL being a relatively rare cancer, it is often hard to find studies specific to our cancer....
AussieNeil profile image
Partner

Has your state prioritized cancer patients to receive the COVID-19 vaccine? Use our link to find out CLL Society has called every state + DC

The COVID-19 vaccine! Has your state prioritized cancer patients to receive the COVID-19 vaccine?...
bkoffman profile image
CLL CURE Hero